Repositorio Dspace

Listar por tema "Immunocompromised Host"

Listar por tema "Immunocompromised Host"

Ordenar por:Orden:Resultados:

  • Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM) 
    González-Cao, María; Puertolas, Teresa; Riveiro, Mar; Muñoz-Couselo, Eva; Ortiz, Carolina; Paredes, Roger; Podzamczer, Daniel; Manzano, José-Luis; Molto, José; Revollo, Boris; Carrera, Cristina; Mateu, Lourdes; Fancelli, Sara; Espinosa, Enrique; Clotet, Bonaventura; Martínez-Picado, Javier; Cerezuela, Pablo; Soria, Ainara; Márquez, Ivan; Mandala, Mario; Berrocal, Alfonso (BMJ PUBLISHING GROUP, 2021)
    Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown durable clinical benefit and survival improvement ...
  • Cutaneous Leishmaniasis in Patients under Biologic Therapies: A Spanish CLINI-AEDV Multicentre Study 
    Ciudad, Andrea; Pujol, Ramón-M; Gallardo, Fernando; Lasheras-Pérez, Miguel-Antonio; Botella-Estrada, Rafael; Armengot-Carbo, Miquel; Fernández-Tapia, Verónica; Mas-Matas, Bernat; Sola-Truyols, Amador; Aguado-Vázquez, Álvaro; Ballester-Nortes, Irene; Llamas-Velasco, Mar; Esquius-Rafat, Mireia; Fuertes, Irene; Masferrer, Emili; Roe-Crespo, Esther; de-La-Vega-Ruiz, Diego; Rocamora-Durán, Vicenc; Imbernon-Moya, Adrián; Blanes-Martínez, María-del-Mar; Garbayo-Salmons, Patricia; Alonso-Naranjo, Laura; Mercader-García, Pedro; Exposito-Serrano, Vicente; Pesque, David; Descalzo, Miguel-Ángel; García-Doval, Ignacio; Martin-Ezquerra, Gemma (ACTA DERMATO-VENEREOLOGICA, 2026-03-12)
    Anti-TNF? agents have been associated with the reactivation of granulomatous infections, including leishmaniasis. Cases of atypical or recurrent cutaneous (CL) or mucocutaneous leishmaniasis (MCL) have been reported in ...
  • Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm 
    Valero-López, G; Carreón-Guarnizo, Ester; Hernández-Clares, Rocío; Iniesta-Martínez, F; Jiménez-Veiga, J; Moreno-Docón, Antonio; Iborra-Bendicho, Asunción; Aznar-Robles, E; Hellín-Gil, María-Fuensanta; Morales-Ortiz, A; Meca-Lallana, José-Eustasio (ELSEVIER ESPANA SLU, 2020-07)
    INTRODUCTION: The COVID-19 pandemic is changing approaches to diagnosis, treatment, and care provision in multiple sclerosis (MS). During both the initial and peak phases of the epidemic, the administration of disease-modifying ...
  • Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients 
    López, Verónica; Vázquez, Teresa; Alonso-Titos, Juana; Cabello, Mercedes; Alonso, Ángel; Beneyto, Isabel; Crespo, Marta; Díaz-Corte, Carmen; Franco, Antonio; González-Roncero, Francisco; Gutiérrez, Elena; Guirado, Luis; Jiménez, Carlos; Jironda, Cristina; Lauzurica-Valdemoros, Ricardo; Llorente, Santiago; Mazuecos, Auxiliadora; Paul, Javier; Rodríguez-Benot, Alberto; Ruiz, Juan-Carlos; Sánchez-Fructuoso, Ana; Sola, Eugenia; Torregrosa, Vicente; Zarraga, Sofia; Hernández, Domingo (SOC ESPANOLA NEFROLOGIA DR RAFAEL MATESANZ, 2020-05)
    The SARS-CoV-2 (Covid-19) coronavirus pandemic is evolving very quickly and means a special risk for both immunosuppressed and comorbid patients. Knowledge about this growing infection is also increasing although many ...